Epsilon M&A Deal Report - deCODE genetics
Transaction Multiples for the Valuation of Private Companies
Amgen / deCODE genetics
No EMAT :
67540
Announced Date :
10/12/2012
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Amgen
Target :
deCODE genetics
Country :
Iceland
Sector of activity :
- Health, Pharmaceuticals & Biotechnology > Biotechnology
Business Description :
Founded in 1996 by Kari Stefansson, deCODE Genetics is a human genetics company, discovers genetic risk factors for diseases ranging from cardiovascular disease to cancer. > Generates and analyzes...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
Rating :
*
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Biotechnology » = 42
| Date | Acquirer | Target | Country | Multiples | See details |
| 19/09/2012 | Illumina | Bluegnome | England | ** | 67500 |
| 16/01/2014 | Eurofins Scientific | IDmyk (now Eurofins ID Myk) | France | ** | 67214 |
Source: Epsilon Research / EMAT
